FDA Approved Alzheimer's Drug Despite Some Staff Concerns
Statisticians at the Food and Drug Administration said there wasn't enough evidence to approve the drug from Biogen, and the agency's decision to approve the drug has sparked criticism.
Amazon's Planned Purchase of MGM Faces FTC Scrutiny
The antitrust review of the acquisition comes as Lina Khan, a frequent critic of the online giant, takes the helm at the commission.
LinkedIn Accounts of Scholars Blocked in China
Affected users say the social-networking site owned by Microsoft is obstructing them over "prohibited content" without further explanation.
Philip Morris International to Move Headquarters to Connecticut
The tobacco company plans to move 200 jobs to a not-yet-named location in the southwestern part of the state from New York City.
McDonald's Loyalty Program Goes National
Customers will receive points on qualifying purchases that can be traded for items under the program, which is set to launch nationally on July 8.
Google Faces EU Antitrust Probe of Alleged Ad-Tech Abuses
The European Union opened a formal antitrust investigation into allegations that Google abuses its leading role in the advertising-technology sector, the most wide-ranging case yet to look at that pillar of the tech giant's business.
Blackstone Bets $6 Billion on Buying and Renting Homes
The investment firm's deal for a company that buys and rents single-family homes is the latest sign Wall Street believes the U.S. housing market is going to stay hot.
Vivendi Shareholders Approve Spinoff of Universal Music
The vote brings the world's largest music company a step closer to becoming its own public entity.
Lux Capital Leads $51 Million Financing in Biotech Startup Enveda
Lux Capital has led a $51 million venture-capital financing in Enveda Biosciences.
Pear Therapeutics to Go Public in Roughly $1.6 Billion SPAC Deal
Investors that include the Pritzker Vlock Family Office and Neuberger Berman Group funds are backing a roughly $125 million private investment in public equity, or PIPE, as part of the proposed deal.
(END) Dow Jones Newswires